FLECA-ED trial. Flecainide for acute atrial fibrillation cardioversion in ischemic heart disease

14 April 2026 (10:45 - 10:55)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science: ablation and drug therapy Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo

Hippokration General Hospital, Athens (Greece)

11 More presentations in this session

The Event

Event poster

EHRA 2026

14 April 2026 10:45 CET